These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6333507)

  • 1. Blood monoamine oxidases and CT scans in subgroups of chronic schizophrenics.
    Tachiki KH; Kurtz N; Kling AS; Hullett FJ
    J Psychiatr Res; 1984; 18(3):233-43. PubMed ID: 6333507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are paranoid schizophrenics biologically different from other schizophrenics?
    Potkin SG; Cannon HE; Murphy DL; Wyatt RJ
    N Engl J Med; 1978 Jan; 298(2):61-6. PubMed ID: 619236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex uno multi: subtyping the schizophrenic syndrome.
    Jeste DV; Kleinman JE; Potkin SG; Luchins DJ; Weinberger DR
    Biol Psychiatry; 1982 Feb; 17(2):199-222. PubMed ID: 6122474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.
    Mann JJ; Kaplan RD; Georgotas A; Friedman E; Branchey M; Gershon S
    Psychopharmacology (Berl); 1981; 74(4):344-8. PubMed ID: 6794079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
    Meltzer HY; Zureick JL
    Psychiatry Res; 1987 Oct; 22(2):99-109. PubMed ID: 3685225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis.
    Zureick JL; Meltzer HY
    Biol Psychiatry; 1988 May; 24(1):63-78. PubMed ID: 3285902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls.
    Orologas AG; Buckman TD; Eiduson S
    Neurosci Lett; 1986 Aug; 68(3):293-8. PubMed ID: 3748456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics. Measurement by the standardized Luria-Nebraska Neuropsychological Battery.
    Golden CJ; Moses JA; Zelazowski R; Graber B; Zatz LM; Horvath TB; Berger PA
    Arch Gen Psychiatry; 1980 Jun; 37(6):619-23. PubMed ID: 6966917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylserine inhibition of monoamine oxidase in platelets of schizophrenics.
    Tachiki KH; Buckman TD; Eiduson S; Kling AS; Hullett J
    Biol Psychiatry; 1986 Jan; 21(1):59-68. PubMed ID: 3942801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood tryptophan metabolism in chronic schizophrenics.
    Freedman DX; Belendiuk K; Belendiuk GW; Crayton JW
    Arch Gen Psychiatry; 1981 Jun; 38(6):655-9. PubMed ID: 7247628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.